{"disease":{"id":"bladder-cancer-treatment","name":"bladder cancer treatment"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07402317","title":"Trimodality Bladder Preservation","phase":"NA","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Al-Azhar University","has_results":false},{"nct_id":"NCT05757336","title":"Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Lu Wang, MD, PhD","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}